Cargando…

Comparing CABG and PCI across the globe based on current regional registry evidence

There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldonazo, Tulio, Kirov, Hristo, Riedel, Leoni Lu, Gaudino, Mario, Doenst, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780238/
https://www.ncbi.nlm.nih.gov/pubmed/36550130
http://dx.doi.org/10.1038/s41598-022-25853-4
_version_ 1784856792441815040
author Caldonazo, Tulio
Kirov, Hristo
Riedel, Leoni Lu
Gaudino, Mario
Doenst, Torsten
author_facet Caldonazo, Tulio
Kirov, Hristo
Riedel, Leoni Lu
Gaudino, Mario
Doenst, Torsten
author_sort Caldonazo, Tulio
collection PubMed
description There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different regions in the world. We systematically searched MEDLINE selecting studies that compared outcomes for CABG or PCI as a treatment for CAD in the last 10 years. Reports without all-cause mortality, multi-national cohorts, hybrid revascularization populations were excluded. Qualifying studies were statistically compared, and their geographic location visualized on a world map. From 5126 studies, one randomized and twenty-two observational studies (19 risk-adjusted) met the inclusion criteria. The mean follow-up was 4.7 ± 7 years and 18 different countries were included. In 17 studies, CABG was associated with better survival during follow-up, six studies showed no significant difference, and no study favored PCI. Periprocedural mortality was not different in seven, lower with PCI in one, lower with CABG in three and not reported in 12 studies. In regional registry-type comparisons, CABG is associated with better long-term survival compared to PCI in most regions of the world without evidence for higher periprocedural mortality.
format Online
Article
Text
id pubmed-9780238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97802382022-12-24 Comparing CABG and PCI across the globe based on current regional registry evidence Caldonazo, Tulio Kirov, Hristo Riedel, Leoni Lu Gaudino, Mario Doenst, Torsten Sci Rep Article There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different regions in the world. We systematically searched MEDLINE selecting studies that compared outcomes for CABG or PCI as a treatment for CAD in the last 10 years. Reports without all-cause mortality, multi-national cohorts, hybrid revascularization populations were excluded. Qualifying studies were statistically compared, and their geographic location visualized on a world map. From 5126 studies, one randomized and twenty-two observational studies (19 risk-adjusted) met the inclusion criteria. The mean follow-up was 4.7 ± 7 years and 18 different countries were included. In 17 studies, CABG was associated with better survival during follow-up, six studies showed no significant difference, and no study favored PCI. Periprocedural mortality was not different in seven, lower with PCI in one, lower with CABG in three and not reported in 12 studies. In regional registry-type comparisons, CABG is associated with better long-term survival compared to PCI in most regions of the world without evidence for higher periprocedural mortality. Nature Publishing Group UK 2022-12-22 /pmc/articles/PMC9780238/ /pubmed/36550130 http://dx.doi.org/10.1038/s41598-022-25853-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Caldonazo, Tulio
Kirov, Hristo
Riedel, Leoni Lu
Gaudino, Mario
Doenst, Torsten
Comparing CABG and PCI across the globe based on current regional registry evidence
title Comparing CABG and PCI across the globe based on current regional registry evidence
title_full Comparing CABG and PCI across the globe based on current regional registry evidence
title_fullStr Comparing CABG and PCI across the globe based on current regional registry evidence
title_full_unstemmed Comparing CABG and PCI across the globe based on current regional registry evidence
title_short Comparing CABG and PCI across the globe based on current regional registry evidence
title_sort comparing cabg and pci across the globe based on current regional registry evidence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780238/
https://www.ncbi.nlm.nih.gov/pubmed/36550130
http://dx.doi.org/10.1038/s41598-022-25853-4
work_keys_str_mv AT caldonazotulio comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence
AT kirovhristo comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence
AT riedelleonilu comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence
AT gaudinomario comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence
AT doensttorsten comparingcabgandpciacrosstheglobebasedoncurrentregionalregistryevidence